A detailed history of Gts Securities LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Gts Securities LLC holds 18,400 shares of NBIX stock, worth $2.31 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
18,400
Previous 9,900 85.86%
Holding current value
$2.31 Million
Previous $1.36 Million 55.51%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$114.58 - $153.15 $593,180 - $792,857
-5,177 Reduced 65.38%
2,741 $315,000
Q2 2024

Aug 14, 2024

BUY
$130.86 - $143.19 $1.04 Million - $1.13 Million
7,918 New
7,918 $1.09 Million

Others Institutions Holding NBIX

About NEUROCRINE BIOSCIENCES INC


  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $12B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Gts Securities LLC Portfolio

Follow Gts Securities LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gts Securities LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gts Securities LLC with notifications on news.